Press Release

Shoulder Innovations Announces Full Commercial Launch of the InSet™ 70 Humeral Stem

Press Release / September 22, 2025

Expansion of the I-Series Humeral Stem Product Line Further Strengthens Robust Shoulder Arthroplasty Portfolio Grand Rapids, MI – September 22, 2025 – Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company exclusively focused on transforming the shoulder surgical care market, today announced the full commercial launch of the InSet™ 70 Humeral Stem (“InSet™ 70”). The […]

Shoulder Innovations Announces Full Commercial Launch of the InSet™ 70 Humeral Stem Read More »

Shoulder Innovations Reports Second Quarter 2025 Financial Results

Press Release / September 9, 2025

GRAND RAPIDS, Mich., Sept. 9, 2025 /PRNewswire/ — Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the second quarter ended June 30, 2025. Recent Business Highlights “We are pleased with both our second quarter performance, which was in-line

Shoulder Innovations Reports Second Quarter 2025 Financial Results Read More »

Nanochon Announces Health Canada Approval for First in Human Investigation

Press Release / July 11, 2025

Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage defects in the knee, is thrilled to announce that it was granted Health Canada approval for their first in human clinical trial. The trial will be led by Principal Investigator, Dr. Fathi Abuzgaya, who will collaborate with

Nanochon Announces Health Canada Approval for First in Human Investigation Read More »

cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer

Press Release / June 24, 2025

RAND RAPIDS, MI – June 24, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce that its portfolio company, Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, has appointed Jim Alecxih as chief executive officer. Alecxih, a recognized commercial leader in the medical device industry,

cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer Read More »

cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum

Press Release / June 11, 2025

Grand Rapids, MI – June 11, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce the acquisition of its portfolio company, Sterile Processing Express (SPDx), by Instrumentum, LLC, a fast-growing leader in surgical instrument sterilization services. This strategic acquisition expands Instrumentum’s operational footprint to five facilities across four states, significantly enhancing its capacity

cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum Read More »

Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing

Press Release / March 10, 2025

Grand Rapids, MI – March 10, 2025 – Shoulder Innovations, a cultivate(MD) portfolio company, and a leader in shoulder replacement technology, today announced the closing of a $40 million Series E equity financing round. The financing was led by existing investor U.S. Venture Partners (USVP), with support from additional existing investors including Gilde Healthcare Partners, Gilmartin Capital,

Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing Read More »